Item 4 — Purpose of Transaction
The Reporting Persons are filing this Amendment No. 6 to report a change in its intentions. Item 4 of the Amended Statement is hereby amended and supplemented by adding the following at the end of Item 4 of the Amended Statement: On July 18, 2025, the Reporting Persons, though their affiliate Hoffmann Family of Companies ("Hoffmann), delivered a letter (the "July 2025 Letter") to the Issuer's Board of Directors and management, proposing a potential transaction in which Hoffmann would purchase $25 million of the Issuer's common shares ("Common Shares") at a purchase price of $2.00 per Common Share, and the Issuer would offer an additional $25 million of Shares to its existing shareholders, at the same purchase price of $2.0 per Common Share, in a rights offering that would be fully backstopped by Hoffmann. The proposed transaction and resulting capital structure implies a pre-money enterprise valution of the Issuer of approximately $462 million, based on the Issuer's current long-term debt obligations and number of outstanding Shares. In connection with the proposed transaction, the July 2025 Letter includes a request by Hoffmann that the Issuer consider an amendment or waiver of provisions of its existing Rights Agreement dated March 28, 2024 and amended on March 26, 2025, pursuant to which the Issuer's shareholders have been issued rights to purchase shares of the Issuer's preferred stock upon the attainment by any person of beneficial ownership of 15% or more of the Issuer's Common Shares. The July 2025 Letter follows prior communications and preliminary discussions between the Issuer and the Reporting Persons regarding potential transactions involving the recapitalization of the Issuer in a manner intended to benefit the shareholders and other stakeholders. Further details regarding the proposal are set forth in the July 2025 Letter dated July 18, 2025 and attached to this Statement as Exhibit 99.1. There can be no assurance that the Reporting Persons or its Affiliates and Issuer will commence or complete a potential transaction, or that the Reporting Persons will or will not develop any alternative plans with respect to their investment in the Issuer. Except as described in this Item 4 or as would occur upon the completion of a transaction as described herein, as of the date of this Amendment No. 6, the Reporting Persons have no present plan or proposal that relates to or would result in any of the matters set forth in subsections (1) through (j) of Schedule 13D. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the outcome of any discussions and negotiations related to the proposed transaction described above, the Issuer's financial position, results and strategic direction, actions taken by the Issuer's management and Board, price levels of the Common Shares and other investment opportunities available to the Reporting Persons, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, acquiring additional Common Stock and/or other equity or other securities of the Issuer or disposing of some or all of the securities beneficially owned by them in public market or privately negotiated transactions and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D. As of the date of this Amendment No. 6, the Reporting Persons have no intent to pursue acquisition of the Issuer through a tender offer or other hostile means, and nothing in this Amendment No. 6 or any discussions of a proposed transaction is meant to be, or should be construed as, an offer to buy any of the Issuer's securities.